Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 313 to 321 of 321 entries
Sorted by: Best Match Show Resources per page
The role of factor XIII in surgery for advanced stage of epithelial ovarian cancer.

Archives of gynecology and obstetrics

Yazdian M, Groeben H, Ataseven B, Schneider S, Baert T, Bommert M, Traut A, Elfers-Wassenhoven A, Brüß U, Schwameis R, du Bois A, Wagner U, Harter P.
PMID: 34724570
Arch Gynecol Obstet. 2021 Nov 01; doi: 10.1007/s00404-021-06308-z. Epub 2021 Nov 01.

INTRODUCTION: Hereditary factor (F) XIII-deficiency is a known risk factor for postoperative complications, but data of acquired FXIII-deficiency in malignancies are limited. Therefore, we evaluated the role of acquired FXIII-deficiency in surgery for advanced epithelial ovarian cancer (EOC).MATERIALS AND...

Cite
Yazdian M, Groeben H, Ataseven B, et al. The role of factor XIII in surgery for advanced stage of epithelial ovarian cancer. Arch Gynecol Obstet. 2021;doi: 10.1007/s00404-021-06308-z.
Yazdian, M., Groeben, H., Ataseven, B., Schneider, S., Baert, T., Bommert, M., Traut, A., Elfers-Wassenhoven, A., Brüß, U., Schwameis, R., du Bois, A., Wagner, U., & Harter, P. (2021). The role of factor XIII in surgery for advanced stage of epithelial ovarian cancer. Archives of gynecology and obstetrics, . https://doi.org/10.1007/s00404-021-06308-z
Yazdian, Mahtab, et al. "The role of factor XIII in surgery for advanced stage of epithelial ovarian cancer." Archives of gynecology and obstetrics vol. (2021). doi: https://doi.org/10.1007/s00404-021-06308-z
Yazdian M, Groeben H, Ataseven B, Schneider S, Baert T, Bommert M, Traut A, Elfers-Wassenhoven A, Brüß U, Schwameis R, du Bois A, Wagner U, Harter P. The role of factor XIII in surgery for advanced stage of epithelial ovarian cancer. Arch Gynecol Obstet. 2021 Nov 01; doi: 10.1007/s00404-021-06308-z. Epub 2021 Nov 01. PMID: 34724570.
Copy Download .nbib Format: NLM
Qualitative and Quantitative Detection of SARS-CoV-2 Antibodies from Dried Blood Spots.

Clinical biochemistry

Omosule CL, Conklin J, Seck S, Howell R, Hock KG, Ballman C, Freeman J, Du Toit L, Dubberke E, Farnsworth CW.
PMID: 34990593
Clin Biochem. 2022 Jan 03; doi: 10.1016/j.clinbiochem.2021.12.012. Epub 2022 Jan 03.

INTRODUCTION: Dried blood spot (DBS) sampling is a minimally invasive method for specimen collection with potential multifaceted uses, particularly for serosurveillance of previous SARS-CoV-2 infection. In this study, we assessed DBS as a potential specimen type for assessing IgG...

Cite
Omosule CL, Conklin J, Seck S, et al. Qualitative and Quantitative Detection of SARS-CoV-2 Antibodies from Dried Blood Spots. Clin Biochem. 2022;doi: 10.1016/j.clinbiochem.2021.12.012.
Omosule, C. L., Conklin, J., Seck, S., Howell, R., Hock, K. G., Ballman, C., Freeman, J., Du Toit, L., Dubberke, E., & Farnsworth, C. W. (2022). Qualitative and Quantitative Detection of SARS-CoV-2 Antibodies from Dried Blood Spots. Clinical biochemistry, . https://doi.org/10.1016/j.clinbiochem.2021.12.012
Omosule, Catherine L, et al. "Qualitative and Quantitative Detection of SARS-CoV-2 Antibodies from Dried Blood Spots." Clinical biochemistry vol. (2022). doi: https://doi.org/10.1016/j.clinbiochem.2021.12.012
Omosule CL, Conklin J, Seck S, Howell R, Hock KG, Ballman C, Freeman J, Du Toit L, Dubberke E, Farnsworth CW. Qualitative and Quantitative Detection of SARS-CoV-2 Antibodies from Dried Blood Spots. Clin Biochem. 2022 Jan 03; doi: 10.1016/j.clinbiochem.2021.12.012. Epub 2022 Jan 03. PMID: 34990593; PMCID: PMC8721924.
Copy Download .nbib Format: NLM
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer.

The New England journal of medicine

Harter P, Sehouli J, Vergote I, Ferron G, Reuss A, Meier W, Greggi S, Mosgard BJ, Selle F, Guyon F, Pomel C, Lécuru F, Zang R, Avall-Lundqvist E, Kim JW, Ponce J, Raspagliesi F, Kristensen G, Classe JM, Hillemanns P, Jensen P, Hasenburg A, Ghaem-Maghami S, Mirza MR, Lund B, Reinthaller A, Santaballa A, Olaitan A, Hilpert F, du Bois A.
PMID: 34874631
N Engl J Med. 2021 Dec 02;385(23):2123-2131. doi: 10.1056/NEJMoa2103294.

BACKGROUND: Treatment for patients with recurrent ovarian cancer has been mainly based on systemic therapy. The role of secondary cytoreductive surgery is unclear.METHODS: We randomly assigned patients with recurrent ovarian cancer who had a first relapse after a platinum-free...

Cite
Harter P, Sehouli J, Vergote I, et al. Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer. N Engl J Med. 2021;385(23):2123-2131doi: 10.1056/NEJMoa2103294.
Harter, P., Sehouli, J., Vergote, I., Ferron, G., Reuss, A., Meier, W., Greggi, S., Mosgard, B. J., Selle, F., Guyon, F., Pomel, C., Lécuru, F., Zang, R., Avall-Lundqvist, E., Kim, J. W., Ponce, J., Raspagliesi, F., Kristensen, G., Classe, J. M., Hillemanns, P., Jensen, P., Hasenburg, A., Ghaem-Maghami, S., Mirza, M. R., Lund, B., Reinthaller, A., Santaballa, A., Olaitan, A., Hilpert, F., du Bois, A. (2021). Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer. The New England journal of medicine, 385(23), 2123-2131. https://doi.org/10.1056/NEJMoa2103294
Harter, Philipp, et al. "Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer." The New England journal of medicine vol. 385,23 (2021): 2123-2131. doi: https://doi.org/10.1056/NEJMoa2103294
Harter P, Sehouli J, Vergote I, Ferron G, Reuss A, Meier W, Greggi S, Mosgard BJ, Selle F, Guyon F, Pomel C, Lécuru F, Zang R, Avall-Lundqvist E, Kim JW, Ponce J, Raspagliesi F, Kristensen G, Classe JM, Hillemanns P, Jensen P, Hasenburg A, Ghaem-Maghami S, Mirza MR, Lund B, Reinthaller A, Santaballa A, Olaitan A, Hilpert F, du Bois A. Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer. N Engl J Med. 2021 Dec 02;385(23):2123-2131. doi: 10.1056/NEJMoa2103294. PMID: 34874631.
Copy Download .nbib Format: NLM
Escape from recognition of SARS-CoV-2 Beta variant spike epitopes but overall preservation of T cell immunity.

Science translational medicine

Riou C, Keeton R, Moyo-Gwete T, Hermanus T, Kgagudi P, Baguma R, Valley-Omar Z, Smith M, Tegally H, Doolabh D, Iranzadeh A, Tyers L, Mutavhatsindi H, Tincho MB, Benede N, Marais G, Chinhoyi LR, Mennen M, Skelem S, du Bruyn E, Stek C, de Oliveira T, Williamson C, Moore PL, Wilkinson RJ, Ntusi NAB, Burgers WA, Abrahams F, Ayres F, du Toit E, Goliath RT, Hanekom W, Hardie D, Hsiao NY, Kloverpris H, Korsman S, Lakay F, Lambson B, Leslie A, Makhado Z, Maseko M, Mhlanga D, Naidoo M, Ndhlovu Z, Ngomti A, Oosthuysen B, Ruzive S, Sigal A, Smith T, Valley-Omar Z, van der Westhuizen D, Zvinairo K.
PMID: 34931886
Sci Transl Med. 2021 Dec 21;eabj6824. Epub 2021 Dec 21.

[Figure: see text].

Cite
Riou C, Keeton R, Moyo-Gwete T, et al. Escape from recognition of SARS-CoV-2 Beta variant spike epitopes but overall preservation of T cell immunity. Sci Transl Med. 2021;eabj6824
Riou, C., Keeton, R., Moyo-Gwete, T., Hermanus, T., Kgagudi, P., Baguma, R., Valley-Omar, Z., Smith, M., Tegally, H., Doolabh, D., Iranzadeh, A., Tyers, L., Mutavhatsindi, H., Tincho, M. B., Benede, N., Marais, G., Chinhoyi, L. R., Mennen, M., Skelem, S., du Bruyn, E., Stek, C., de Oliveira, T., Williamson, C., Moore, P. L., Wilkinson, R. J., Ntusi, N. A. B., Burgers, W. A., Abrahams, F., Ayres, F., du Toit, E., Goliath, R. T., Hanekom, W., Hardie, D., Hsiao, N. Y., Kloverpris, H., Korsman, S., Lakay, F., Lambson, B., Leslie, A., Makhado, Z., Maseko, M., Mhlanga, D., Naidoo, M., Ndhlovu, Z., Ngomti, A., Oosthuysen, B., Ruzive, S., Sigal, A., Smith, T., Valley-Omar, Z., van der Westhuizen, D., & Zvinairo, K. (2021). Escape from recognition of SARS-CoV-2 Beta variant spike epitopes but overall preservation of T cell immunity. Science translational medicine, eabj6824.
Riou, Catherine, et al. "Escape from recognition of SARS-CoV-2 Beta variant spike epitopes but overall preservation of T cell immunity." Science translational medicine vol. (2021): eabj6824.
Riou C, Keeton R, Moyo-Gwete T, Hermanus T, Kgagudi P, Baguma R, Valley-Omar Z, Smith M, Tegally H, Doolabh D, Iranzadeh A, Tyers L, Mutavhatsindi H, Tincho MB, Benede N, Marais G, Chinhoyi LR, Mennen M, Skelem S, du Bruyn E, Stek C, de Oliveira T, Williamson C, Moore PL, Wilkinson RJ, Ntusi NAB, Burgers WA, Abrahams F, Ayres F, du Toit E, Goliath RT, Hanekom W, Hardie D, Hsiao NY, Kloverpris H, Korsman S, Lakay F, Lambson B, Leslie A, Makhado Z, Maseko M, Mhlanga D, Naidoo M, Ndhlovu Z, Ngomti A, Oosthuysen B, Ruzive S, Sigal A, Smith T, Valley-Omar Z, van der Westhuizen D, Zvinairo K. Escape from recognition of SARS-CoV-2 Beta variant spike epitopes but overall preservation of T cell immunity. Sci Transl Med. 2021 Dec 21;eabj6824. Epub 2021 Dec 21. PMID: 34931886.
Copy Download .nbib Format: NLM
Root submergence technique as a partial extraction therapy to preserve the alveolar ridge tissues: A systematic review and appraisal of the literature.

The Journal of prosthetic dentistry

Du Toit J, Salama M, Gluckman H, Nagy K.
PMID: 34750013
J Prosthet Dent. 2021 Nov 05; doi: 10.1016/j.prosdent.2021.08.009. Epub 2021 Nov 05.

STATEMENT OF PROBLEM: As socket grafting with commercially available biomaterials has become popular, reports of the root submergence technique for ridge preservation have decreased. A systematic review of this partial extraction therapy is lacking.PURPOSE: The purpose of this systematic...

Cite
Du Toit J, Salama M, Gluckman H, et al. Root submergence technique as a partial extraction therapy to preserve the alveolar ridge tissues: A systematic review and appraisal of the literature. J Prosthet Dent. 2021;doi: 10.1016/j.prosdent.2021.08.009.
Du Toit, J., Salama, M., Gluckman, H., & Nagy, K. (2021). Root submergence technique as a partial extraction therapy to preserve the alveolar ridge tissues: A systematic review and appraisal of the literature. The Journal of prosthetic dentistry, . https://doi.org/10.1016/j.prosdent.2021.08.009
Du Toit, Jonathan, et al. "Root submergence technique as a partial extraction therapy to preserve the alveolar ridge tissues: A systematic review and appraisal of the literature." The Journal of prosthetic dentistry vol. (2021). doi: https://doi.org/10.1016/j.prosdent.2021.08.009
Du Toit J, Salama M, Gluckman H, Nagy K. Root submergence technique as a partial extraction therapy to preserve the alveolar ridge tissues: A systematic review and appraisal of the literature. J Prosthet Dent. 2021 Nov 05; doi: 10.1016/j.prosdent.2021.08.009. Epub 2021 Nov 05. PMID: 34750013.
Copy Download .nbib Format: NLM
Effect of chronic restraint stress and western-diet feeding on colonic regulatory gene expression in mice.

Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society

Hatton-Jones KM, du Toit EF, Cox AJ.
PMID: 34825433
Neurogastroenterol Motil. 2021 Nov 26;e14300. doi: 10.1111/nmo.14300. Epub 2021 Nov 26.

BACKGROUND: Diet-induced obesity (DIO) and psychological stress are significant independent regulators of gastrointestinal physiology; however, our understanding of how these two disorders influence the host-microbe interface is still poorly characterized. The aim of this study was to assess the...

Cite
Hatton-Jones KM, du Toit EF, Cox AJ. Effect of chronic restraint stress and western-diet feeding on colonic regulatory gene expression in mice. Neurogastroenterol Motil. 2021;e14300doi: 10.1111/nmo.14300.
Hatton-Jones, K. M., du Toit, E. F., & Cox, A. J. (2021). Effect of chronic restraint stress and western-diet feeding on colonic regulatory gene expression in mice. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society, e14300. https://doi.org/10.1111/nmo.14300
Hatton-Jones, Kyle M, et al. "Effect of chronic restraint stress and western-diet feeding on colonic regulatory gene expression in mice." Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society vol. (2021): e14300. doi: https://doi.org/10.1111/nmo.14300
Hatton-Jones KM, du Toit EF, Cox AJ. Effect of chronic restraint stress and western-diet feeding on colonic regulatory gene expression in mice. Neurogastroenterol Motil. 2021 Nov 26;e14300. doi: 10.1111/nmo.14300. Epub 2021 Nov 26. PMID: 34825433.
Copy Download .nbib Format: NLM
Cell-Free-DNA-Based Copy Number Index Score in Epithelial Ovarian Cancer-Impact for Diagnosis and Treatment Monitoring.

Cancers

Braicu EI, du Bois A, Sehouli J, Beck J, Prader S, Kulbe H, Eiben B, Harter P, Traut A, Pietzner K, Glaubitz R, Ataseven B, Chekerov R, Keck C, Winkler T, Heikaus S, Gellendin P, Schütz E, Heitz F.
PMID: 35008332
Cancers (Basel). 2021 Dec 30;14(1). doi: 10.3390/cancers14010168.

BACKGROUND: Chromosomal instability, a hallmark of cancer, results in changes in the copy number state. These deviant copy number states can be detected in the cell-free DNA (cfDNA) and provide a quantitative measure of the ctDNA levels by converting...

Cite
Braicu EI, du Bois A, Sehouli J, et al. Cell-Free-DNA-Based Copy Number Index Score in Epithelial Ovarian Cancer-Impact for Diagnosis and Treatment Monitoring. Cancers (Basel). 2021;14(1)doi: 10.3390/cancers14010168.
Braicu, E. I., du Bois, A., Sehouli, J., Beck, J., Prader, S., Kulbe, H., Eiben, B., Harter, P., Traut, A., Pietzner, K., Glaubitz, R., Ataseven, B., Chekerov, R., Keck, C., Winkler, T., Heikaus, S., Gellendin, P., Schütz, E., & Heitz, F. (2021). Cell-Free-DNA-Based Copy Number Index Score in Epithelial Ovarian Cancer-Impact for Diagnosis and Treatment Monitoring. Cancers, 14(1), . https://doi.org/10.3390/cancers14010168
Braicu, Elena Ioana, et al. "Cell-Free-DNA-Based Copy Number Index Score in Epithelial Ovarian Cancer-Impact for Diagnosis and Treatment Monitoring." Cancers vol. 14,1 (2021). doi: https://doi.org/10.3390/cancers14010168
Braicu EI, du Bois A, Sehouli J, Beck J, Prader S, Kulbe H, Eiben B, Harter P, Traut A, Pietzner K, Glaubitz R, Ataseven B, Chekerov R, Keck C, Winkler T, Heikaus S, Gellendin P, Schütz E, Heitz F. Cell-Free-DNA-Based Copy Number Index Score in Epithelial Ovarian Cancer-Impact for Diagnosis and Treatment Monitoring. Cancers (Basel). 2021 Dec 30;14(1). doi: 10.3390/cancers14010168. PMID: 35008332; PMCID: PMC8750971.
Copy Download .nbib Format: NLM
Is Haploidentical Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide Feasible in Sub-Saharan Africa?.

Transplantation and cellular therapy

du Toit JR, Mcdonald A, Brittain D, Cass M, Thomson J, Oosthuizen J, du Toit C, Seftel M, Louw VJ, Verburgh E.
PMID: 34478910
Transplant Cell Ther. 2021 Dec;27(12):1002.e1-1002.e8. doi: 10.1016/j.jtct.2021.08.018. Epub 2021 Aug 31.

Identifying a suitable volunteer unrelated donor (UD) in South Africa is challenging due to the highly diverse ethnic groups and mixed-race populations in this region. Haploidentical hematopoietic cell transplantation (haploHCT) is thus an attractive procedure for patients with high-risk...

Cite
du Toit JR, Mcdonald A, Brittain D, et al. Is Haploidentical Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide Feasible in Sub-Saharan Africa?. Transplant Cell Ther. 2021;27(12):1002.e1-1002.e8doi: 10.1016/j.jtct.2021.08.018.
du Toit, J. R., Mcdonald, A., Brittain, D., Cass, M., Thomson, J., Oosthuizen, J., du Toit, C., Seftel, M., Louw, V. J., & Verburgh, E. (2021). Is Haploidentical Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide Feasible in Sub-Saharan Africa?. Transplantation and cellular therapy, 27(12), 1002.e1-1002.e8. https://doi.org/10.1016/j.jtct.2021.08.018
du Toit, Justin Rudolph, et al. "Is Haploidentical Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide Feasible in Sub-Saharan Africa?." Transplantation and cellular therapy vol. 27,12 (2021): 1002.e1-1002.e8. doi: https://doi.org/10.1016/j.jtct.2021.08.018
du Toit JR, Mcdonald A, Brittain D, Cass M, Thomson J, Oosthuizen J, du Toit C, Seftel M, Louw VJ, Verburgh E. Is Haploidentical Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide Feasible in Sub-Saharan Africa?. Transplant Cell Ther. 2021 Dec;27(12):1002.e1-1002.e8. doi: 10.1016/j.jtct.2021.08.018. Epub 2021 Aug 31. PMID: 34478910.
Copy Download .nbib Format: NLM
SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021.

medRxiv : the preprint server for health sciences

Cohen C, Kleynhans J, von Gottberg A, McMorrow ML, Wolter N, Bhiman JN, Moyes J, du Plessis M, Carrim M, Buys A, Martinson NA, Kahn K, Tollman S, Lebina L, Wafawanaka F, du Toit J, Gómez-Olivé FX, Dawood FS, Mkhencele T, Sun K, Viboud C, Tempia S.
PMID: 34909794
medRxiv. 2021 Dec 04; doi: 10.1101/2021.07.20.21260855.

No abstract available.

Cite
Cohen C, Kleynhans J, von Gottberg A, et al. SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021. medRxiv. 2021;doi: 10.1101/2021.07.20.21260855.
Cohen, C., Kleynhans, J., von Gottberg, A., McMorrow, M. L., Wolter, N., Bhiman, J. N., Moyes, J., du Plessis, M., Carrim, M., Buys, A., Martinson, N. A., Kahn, K., Tollman, S., Lebina, L., Wafawanaka, F., du Toit, J., Gómez-Olivé, F. X., Dawood, F. S., Mkhencele, T., Sun, K., Viboud, C., & Tempia, S. (2021). SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.07.20.21260855
Cohen, Cheryl, et al. "SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.07.20.21260855
Cohen C, Kleynhans J, von Gottberg A, McMorrow ML, Wolter N, Bhiman JN, Moyes J, du Plessis M, Carrim M, Buys A, Martinson NA, Kahn K, Tollman S, Lebina L, Wafawanaka F, du Toit J, Gómez-Olivé FX, Dawood FS, Mkhencele T, Sun K, Viboud C, Tempia S. SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021. medRxiv. 2021 Dec 04; doi: 10.1101/2021.07.20.21260855. PMID: 34909794; PMCID: PMC8669861.
Copy Download .nbib Format: NLM
Showing 313 to 321 of 321 entries